Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Sunitinib Malate.

Client Email

Product

Sunitinib Malate
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Sunitinib Malate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 12 USDMF, 1 JDMF, 9 EU WC, 6 KDMF, 7 NDC API, 34 Listed Suppliers, $ API Reference Price

42 API Suppliers
12 USDMF
1 JDMF
9 EU WC
6 KDMF
7 NDC API
34 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

19 Drugs in Development

19 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

INTERMEDIATES

18 API Suppliers

18 API Suppliers

FINISHED DOSAGE FORMULATIONS

217 FDF Dossiers, 35 FDA Orange Book, 34 Europe, 15 Canada, 90 Australia, 7 South Africa, 36 Listed Dossiers

217 FDF Dossiers
35 FDA Orange Book
34 Europe
15 Canada
90 Australia
7 South Africa
36 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 7 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 2 Kerry, 3 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 6 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 16 Direct Compression, 14 Disintegrants & Superdisintegrants, 10 Chewable & Orodispersible Aids, 10 Granulation, 10 Taste Masking, 9 Solubilizers, 8 Thickeners and Stabilizers, 8 Lubricants & Glidants, 8 Empty Capsules, 7 Coating Systems & Additives, 7 Parenteral, 5 Co-Processed Excipients, 5 Film Formers & Plasticizers, 4 Controlled & Modified Release, 3 Coloring Agents, 3 Topical, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Rheology Modifiers

36 Fillers, Diluents & Binders
16 Direct Compression
14 Disintegrants & Superdisintegrants
10 Chewable & Orodispersible Aids
10 Granulation
10 Taste Masking
9 Solubilizers
8 Thickeners and Stabilizers
8 Lubricants & Glidants
8 Empty Capsules
7 Coating Systems & Additives
7 Parenteral
5 Co-Processed Excipients
5 Film Formers & Plasticizers
4 Controlled & Modified Release
3 Coloring Agents
3 Topical
2 Emulsifying Agents
1 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 60 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
60 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 25 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
25 Finished Drug Prices
10 Annual Reports

MARKET PLACE

16 APIs, 10 FDF Dossiers

16 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 Health Canada Patents

16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ API Ref.Price (USD/KG) : 5,785 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

16 All

01 16Pfizer Canada ULC

filter Patent Reset all filters

16 All

01 42395461

02 42399358

03 42455050

04 42498415

filter Product Reset all filters

16 All

01 16Sunitinib Malate

filter Dosage Reset all filters

16 All

01 16Capsule

filter Exp Date Reset all filters

16 All

01 42020-12-22

02 42021-02-15

03 42022-08-13

04 42023-09-10

Product Main Page

01

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Brand Name : SUTENT

Patent Number : 2455050

Filing Date : 2002-08-13

Strength per Unit : 12.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Brand Name : SUTENT

Patent Number : 2498415

Filing Date : 2003-09-10

Strength per Unit : 12.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Brand Name : SUTENT

Patent Number : 2399358

Filing Date : 2001-02-15

Strength per Unit : 12.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Brand Name : SUTENT

Patent Number : 2455050

Filing Date : 2002-08-13

Strength per Unit : 25mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Brand Name : SUTENT

Patent Number : 2498415

Filing Date : 2003-09-10

Strength per Unit : 25mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Brand Name : SUTENT

Patent Number : 2399358

Filing Date : 2001-02-15

Strength per Unit : 25mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Portfolio PDF

Product Web Link

Digital Content

07

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Brand Name : SUTENT

Patent Number : 2455050

Filing Date : 2002-08-13

Strength per Unit : 50mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-08-13

Date Granted : 2007-02-20

Portfolio PDF

Product Web Link

Digital Content

08

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Brand Name : SUTENT

Patent Number : 2399358

Filing Date : 2001-02-15

Strength per Unit : 50mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-02-15

Date Granted : 2006-03-21

Portfolio PDF

Product Web Link

Digital Content

09

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Brand Name : SUTENT

Patent Number : 2498415

Filing Date : 2003-09-10

Strength per Unit : 50mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-29

Portfolio PDF

Product Web Link

Digital Content

10

Pfizer Canada ULC

Sunitinib

Discovery on Target

Not Confirmed

Pfizer Canada ULC

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-28

Brand Name : SUTENT

Patent Number : 2498415

Filing Date : 2003-09-10

Strength per Unit : 37.5mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-09-10

Date Granted : 2007-05-28

Portfolio PDF

Product Web Link

Digital Content

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?